About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
10.45h Bienvenida y presentación del VHIR- Dr. Albert Salazar, gerente del Hospital Universitario Vall d’Hebron- Francesc Trillas, Secretario de Asuntos Económicos y Fondos Europeos, Generalitat de Catalunya- Manuel Szapiro, Director de la Representación de la Comisión Europea en Barcelona- Dra. Begoña Benito, Directora del VHIR
11.10h Contexto y descripción específica del nuevo edificio del VHIR- Montse Giménez, Gerente del VHIR- Jordi Badia, Director del estudio BAAS Arquitectura y arquitecto responsable de la creación del edificio
11.30h Mesa redonda- Modera: Sara Mas, Responsable de impacto social y estrategia RRI- Dra. Ariadna Laguna, Investigadora principal del grupo de Enfermedades Neurodegenerativas del VHIR- Dr. David Gómez, jefe del grupo de Terapias e Innovación en Neuropediatría y otras Enfermedades Raras Pediátricas del VHIR.- Representantes Asociaciones de Pacientes: Laura Morer (Associació Catalana per al Parkinson, ACAP) y Marisol Montolio (Duchenne Parent Project)
12:30h Visita al edificio
INSCRIPCIONES
